Explore the Agenda
议程 | 議題 | Agenda
8:00 am Light Breakfast & Networking
8:55 am Chair’s Opening Remarks
Developing Effective Biomarker Strategies for Cell Therapies, ADCs & Bispecifics to Improve Patient Stratification & Enhance Treatment Efficacy
9:00 am Updates in Developing Effective Biomarker Strategies for CAR-T Therapies
- Showcasing progress in CAR-T for hematologic malignancies
- Reviewing updates and innovation in CAR-T for solid tumors
- Exploring updates on prognostic and predictive biomarkers
9:30 am Session Reserved for BioIVT
Presentation Details to be Announced
10:00 am Organoid-Guided Precision: Advancing Indication Selection in ADC Development
- Physiologically relevant screening platform: Patient-derived organoids (PDOs) retain tumor complexity, offering more predictive ADC response than 2D or animal models
- Integrated target validation and cytotoxicity assessment: Concurrently evaluate antigen expression and ADC potency across cancer types
- Biomarker-driven patient stratification: Link PDOs response with molecular data to identify predictive markers and guide patient selection
10:30 am Panel Discussion: Establishing Scalable & Validated Digital Pathology to Support Patient Selection for ADC Therapies
- Establishing robust validity for digital pathology platforms to ensure reproducibility and accuracy across different laboratories
- What is the regulatory pathway for approving digital pathology based CDx approaches in APAC?
- Designing digital pathology networks to address pathologist shortages and ensure equitable diagnostic access in geographically dispersed APAC regions
11:00 am Morning Networking Break
Navigating CDx Regulation, Reimbursement & Launch Planning Considerations to Accelerate Market & Patient Access in APAC
12:00 pm Navigating IVDR – Reviewing CDx & Critical Milestones
- Transitioning from IVDD to IVDR: current status
- CDx: lessons learnt and looking ahead
12:30 pm Session Reserved for ARC Regulatory
Presentation Details to be Announced
12:40 pm Making Precision Medicine Research/Product Launch Quicker by Leveraging Local Regulatory Strategy
- Reviewing local regulatory strategy
- Showcasing how to make product launch quicker by aligning regulatory knowledge and strategy
1:10 pm Lunch Break
1:55 pm Dedicated Networking Time
Shaping the Future of APAC Healthcare with Precision Therapies in Neurological, Chronic & Rare Disease to Expand Patient Access
2:40 pm Biomarker-Driven Translational & Precision Medicine in Oncology & Neuroscience
- Reviewing clinically validated biomarkers of efficacy and their real-world expression in oncology
- Spotlighting translational research to explore novel efficacy predictive biomarkers
- Leveraging reverse translational approaches to facilitate early discovery
3:10 pm Precision Medicine in Global Health – Opportunities, Challenges & the Road Ahead
- From evidence to policy – genomics for AMR diagnosis and treatment guidance
- Precision medicine for infectious disease: A case for companion diagnostics?
- Partnering to strengthen sequencing capacity and clinical utility in LMICs